Cargando…
HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
BACKGROUND: HIV proteins Nef and Vpu down-modulate various host factors to evade immune defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion-tethering BST2 is depleted by Vpu. Antibody-dependent cell-mediated cytotoxicity (ADCC) is increasingly recognized as a potentia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930549/ https://www.ncbi.nlm.nih.gov/pubmed/24498878 http://dx.doi.org/10.1186/1742-4690-11-15 |
_version_ | 1782304543628853248 |
---|---|
author | Pham, Tram NQ Lukhele, Sabelo Hajjar, Fadi Routy, Jean-Pierre Cohen, Éric A |
author_facet | Pham, Tram NQ Lukhele, Sabelo Hajjar, Fadi Routy, Jean-Pierre Cohen, Éric A |
author_sort | Pham, Tram NQ |
collection | PubMed |
description | BACKGROUND: HIV proteins Nef and Vpu down-modulate various host factors to evade immune defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion-tethering BST2 is depleted by Vpu. Antibody-dependent cell-mediated cytotoxicity (ADCC) is increasingly recognized as a potentially powerful anti-HIV response. Given that epitopes which are specific for ADCC-competent anti-HIV antibodies are transitionally exposed upon CD4-mediated HIV entry, we investigated whether by depleting CD4 and BST2, HIV could negatively affect ADCC function. RESULTS: Using anti-envelope (Env) Abs A32 and 2G12 to trigger ADCC activity, we find that interactions between CD4 and Env within infected cells expose ADCC-targeted epitopes on cell-surface Env molecules, marking infected T cells for lysis by immune cells. We also provide evidence to show that by cross-linking nascent virions at the plasma membrane, hence increasing cell-surface Env density, BST2 further enhances the efficiency of this antiviral process. The heightened susceptibility of T cells infected with a virus lacking Nef and Vpu to ADCC was recapitulated when plasmas from HIV-infected patients were used as an alternative source of Abs. CONCLUSIONS: Our data unveil a mechanism by which HIV Nef and Vpu function synergistically to protect infected cells from ADCC and promote viral persistence. These findings also renew the potential practical relevance of ADCC function in vivo. |
format | Online Article Text |
id | pubmed-3930549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39305492014-02-21 HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 Pham, Tram NQ Lukhele, Sabelo Hajjar, Fadi Routy, Jean-Pierre Cohen, Éric A Retrovirology Research BACKGROUND: HIV proteins Nef and Vpu down-modulate various host factors to evade immune defenses. Indeed, the CD4 receptor is down-regulated by Nef and Vpu, whereas virion-tethering BST2 is depleted by Vpu. Antibody-dependent cell-mediated cytotoxicity (ADCC) is increasingly recognized as a potentially powerful anti-HIV response. Given that epitopes which are specific for ADCC-competent anti-HIV antibodies are transitionally exposed upon CD4-mediated HIV entry, we investigated whether by depleting CD4 and BST2, HIV could negatively affect ADCC function. RESULTS: Using anti-envelope (Env) Abs A32 and 2G12 to trigger ADCC activity, we find that interactions between CD4 and Env within infected cells expose ADCC-targeted epitopes on cell-surface Env molecules, marking infected T cells for lysis by immune cells. We also provide evidence to show that by cross-linking nascent virions at the plasma membrane, hence increasing cell-surface Env density, BST2 further enhances the efficiency of this antiviral process. The heightened susceptibility of T cells infected with a virus lacking Nef and Vpu to ADCC was recapitulated when plasmas from HIV-infected patients were used as an alternative source of Abs. CONCLUSIONS: Our data unveil a mechanism by which HIV Nef and Vpu function synergistically to protect infected cells from ADCC and promote viral persistence. These findings also renew the potential practical relevance of ADCC function in vivo. BioMed Central 2014-02-06 /pmc/articles/PMC3930549/ /pubmed/24498878 http://dx.doi.org/10.1186/1742-4690-11-15 Text en Copyright © 2014 Pham et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Pham, Tram NQ Lukhele, Sabelo Hajjar, Fadi Routy, Jean-Pierre Cohen, Éric A HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 |
title | HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 |
title_full | HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 |
title_fullStr | HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 |
title_full_unstemmed | HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 |
title_short | HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2 |
title_sort | hiv nef and vpu protect hiv-infected cd4+ t cells from antibody-mediated cell lysis through down-modulation of cd4 and bst2 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930549/ https://www.ncbi.nlm.nih.gov/pubmed/24498878 http://dx.doi.org/10.1186/1742-4690-11-15 |
work_keys_str_mv | AT phamtramnq hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2 AT lukhelesabelo hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2 AT hajjarfadi hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2 AT routyjeanpierre hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2 AT cohenerica hivnefandvpuprotecthivinfectedcd4tcellsfromantibodymediatedcelllysisthroughdownmodulationofcd4andbst2 |